Blog Category

All

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Latest Articles

All

Biomarker Validation: Analytical vs Clinical Validation, Step by Step

A step-by-step guide to biomarker validation, from the context of use and fit-for-purpose analytical validation to clinical validation, clinical utility…

Anwesha May 2026
All

Boston Biotech & Life Sciences Events 2027: Complete Guide

The main Boston biotech and life sciences events for 2027, from Biotech Week Boston and Bio-IT World to PEGS and…

Anwesha Apr 2026
All

Tumor Mutational Burden (TMB): From Research to Clinical Reality, 2027 Update

TMB-high at 10 mut/Mb became a tumour-agnostic indication in 2020, but the evidence since shows it predicts checkpoint benefit in…

Anwesha Apr 2026
All

Speaker Spotlight Series: Pioneers Shaping IO Biomarker Science

Speaker Spotlight Series: Pioneers Shaping IO Biomarker Science ImmunoMark Summit | UK Edition 2026 | London ImmunoMark Summit is the…

Anwesha Apr 2026
All

Companion Diagnostics: The Complete Guide to Development, Approval & Co-Development

A pillar guide to companion diagnostics: the FDA definition and approval pathways, EU IVDR class C rules and transition dates,…

Anwesha Apr 2026
All

Immuno-Oncology Conferences 2027: Best Events to Attend & Sponsor

The best immuno-oncology and cancer immunotherapy conferences from Nov 2026 to Nov 2027, with verified dates, locations and who each…

Anwesha Apr 2026
All

PD-L1 Testing in 2027: Assays, Cut-Offs and AI-Assisted Scoring

A refreshed guide to PD-L1 testing: the four FDA companion assays, TPS, CPS and TC/IC scoring, current US cut-offs by…

Anwesha Apr 2026
1 … 3 4 5

Join us for our Upcoming Editions

300+ senior leaders. Two streams. One agenda: advancing precision oncology.

Waitlist for Boston Edition Register for San Diego Edition Register for London Edition